The TB is one of the leading causes of mortality in India. It kills more than 300,000 people in India every year.
India has had an ongoing National TB Program (NTP) since 1962.In order to overcome these lacunae, the Government decided to give a new thrust to TB control activities by revitalizing the NTP, with assistance from international agencies, in 1993.
The Revised National TB Control Programme (RNTCP) thus formulated, adopted the internationally recommended Directly Observed Treatment Short-course (DOTS) strategy, as the most systematic and cost-effective approach to revitalise the TB control programme in India. Large-scale implementation of the RNTCP began in late 1998.
Revised National Tuberculosis Control Program (RNTCP) is
the state-run tuberculosis (TB) control initiative of the Government of India. As per the National Strategic Plan 2012-17, the program has a vision of achieving a "TB free India", and aims to achieve Universal Access to TB control services. The program provides, various free of cost, quality tuberculosis diagnosis and treatment services across the country through the government health system. It seeks to employ the WHO recommended tuberculosis control strategy, DOTS (Directly Observed Treatment, Short Course), to the Indian scenario.
NIKSHAY, the web based reporting for TB programme has been another notable achievement initiated in 2012 and has enabled capture and transfer of individual patient data from the remotest health institutions of the country.
Program strategy
The program initially adopted the WHO-DOTS strategy which consisted of the five components of strong political will and 
Scale-up of joint TB-HIV collaborative activities:
 Activities will aim at early, rapid TB diagnosis with high sensitivity tests for HIV-infected TB suspects and ART for all HIV-infected TB patients, with transport support.
Integration with health systems:
 Integrating the RNTCP with the overall health system will increase effectiveness and efficiencies of TB care and control which has been depicted in the picture. For New TB Case:
1. Treatment will continue for 24 weeks. 3. In Continuation Phase (CP), 3 FDC (H,R,E) will be given instead of 4 FDC as Pyrazinamide will not be administered.
CP phase will be continued for 16 weeks.
4. Both IP and CP phase will be administered as per Daily
Regimen.
For Previously Treated Case of TB:
1. TB patients who has been advised for re-treatment for TB; their treatment will be continued for 32 weeks.
2. IP phase will be for 12 weeks.
3. For 1st 4 weeks Inj. Streptomycin will be administered along with 4 FDC. Out of 12 weeks of IP phase, last 4 weeks only FDC will be continued without Injection Streptomycin.
4. 3FDC will be administered in CP phase for these types of patients. 
